Effect of Hepatosteatosis on the Virological Response in Entecavir and Tenofovir Therapies

KORKMAZ, PINAR; Demirturk, Nese; Batirel, Ayse; Tulek, Necla; Ozguler, Muge; Harman, Rezan; Cinar, Gule; TOKA, ONUR; Yoruk, Gulsen; Ataman-Hatipoglu, Cigdem; Sarigul, Figen; SIRMATEL, FATMA; Imre, Ayfer; MISTANOĞLU ÖZATAĞ, DURU; KARAKEÇİLİ, FARUK; URAL, ONUR; SÜMER, ŞUA; Aktug-Demir, Nazlim; Kadanali, Ayten; Comoglu, Senol; Ucer, Sengul; Saltoglu, Nese; Gunal, Ozgur; Ozkaya, Hacer; Yenilmez, Ercan; Cetinkaya, Riza; Yuksel, Esma; Hakyemez, Ismail; MERİÇ KOÇ, MELİHA; Tuncer-Ertem, Gunay; Bestepe-Dursun, Zehra; Celik, Ilhami; YILMAZ, EMEL; Evik, Guliz; Kaya, Ali; Suer, Kaya

doi:10.5152/kd.2019.73

Effect of Hepatosteatosis on the Virological Response in Entecavir and Tenofovir Therapies

Copy For Citation

KORKMAZ P., Demirturk N., Batirel A., Tulek N., Ozguler M., Harman R., ...More

KLIMIK JOURNAL, vol.32, no.3, pp.265-274, 2019 (ESCI)

Publication Type: Article / Article
Volume: 32 Issue: 3
Publication Date: 2019
Doi Number: 10.5152/kd.2019.73
Journal Name: KLIMIK JOURNAL
Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
Page Numbers: pp.265-274
Hacettepe University Affiliated: Yes

Abstract

Objective: Both chronic hepatitis B (CHB) and hepatosteatosis may lead to necroinflammation in liver. Therefore, the presence of hepatosteatosis might negatively affect the efficacy of antiviral therapy. We aimed to determine the effect of hepatosteatosis on virological response in patients with CHB receiving entecavir (ETV) and tenofovir (TDF) treatment.